These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10821446)

  • 1. Modulation of 5-HT1A receptor mediated response by fluoxetine in rat brain.
    Subhash MN; Srinivas BN; Vinod KY; Jagadeesh S
    J Neural Transm (Vienna); 2000; 107(3):377-87. PubMed ID: 10821446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain.
    Castro M; Diaz A; del Olmo E; Pazos A
    Neuropharmacology; 2003 Jan; 44(1):93-101. PubMed ID: 12559126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet.
    D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van de Kar LD
    Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R390-7. PubMed ID: 14604841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
    Casanovas JM; Vilaró MT; Mengod G; Artigas F
    J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in 5-HT(1A) receptors and adenylyl cyclase response by trazodone in regions of rat brain.
    Subhash MN; Srinivas BN; Vinod KY
    Life Sci; 2002 Aug; 71(13):1559-67. PubMed ID: 12127910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R; Bramante M; Samanin R
    Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
    Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
    Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained desensitization of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited neuroendocrine responses to 8-hydroxy-2-(Dipropylamino)Tetralin in the absence of changes in Gi/o/z proteins.
    Raap DK; Garcia F; Muma NA; Wolf WA; Battaglia G; van de Kar LD
    J Pharmacol Exp Ther; 1999 Feb; 288(2):561-7. PubMed ID: 9918559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine induced selective changes in 5-HT(1A) receptor mediated response in rat brain.
    Vinod KY; Subhash MN
    Neurochem Int; 2002 Apr; 40(4):315-9. PubMed ID: 11792461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic evidence for differential G-protein coupling of 5-HT1A receptors in rat brain: lack of effect of repeated injections of fluoxetine.
    Li Q; Battaglia G; Van de Kar LD
    Brain Res; 1997 Sep; 769(1):141-51. PubMed ID: 9374282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivation in regions of rat brain.
    Vinod KY; Subhash MN; Srinivas BN
    Neurochem Res; 2001 Feb; 26(2):113-20. PubMed ID: 11478737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA; Nguyen HQ; Smith DL; Schechter LE
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U; Merico A; Ermani M; Ori C
    Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of experimental hypothyroidism on 5-HT1A, 5-HT2A receptors, 5-HT uptake sites and tryptophan hydroxylase activity in mature rat brain1.
    Kulikov A; Moreau X; Jeanningros R
    Neuroendocrinology; 1999 Jun; 69(6):453-9. PubMed ID: 10364698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chronic treatment with fluoxetine decreases 5-HT(1A) receptors labeling in mice selected as a genetic model of helplessness.
    Naudon L; El Yacoubi M; Vaugeois JM; Leroux-Nicollet I; Costentin J
    Brain Res; 2002 May; 936(1-2):68-75. PubMed ID: 11988231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.